Gene · 2829
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GWAS reveals genetic basis of a predisposition to severe COVID-19 through in silico modeling of the FYCO1 protein. | Front Med (Lausanne) | 2023 | 37547597 | PubTator, text mining | PubMed |
| A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. | Nat Commun | 2023 | 37542039 | PubTator, text mining | PubMed |
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. | Science | 2023 | 37535729 | PubTator, text mining | PubMed |
| Harnessing neutrophil plasticity for HCC immunotherapy. | Essays Biochem | 2023 | 37534829 | PubTator, text mining | PubMed |
| Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells. | Biology (Basel) | 2023 | 37508464 | PubTator, text mining | PubMed |
| Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial. | Nat Med | 2023 | 37488287 | PubTator, text mining | PubMed |
| Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming. | J Immunother Cancer | 2023 | 37487664 | PubTator, text mining | PubMed |
| Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma. | Front Immunol | 2023 | 37483592 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37475874 | PubTator, text mining | PubMed |
| Lymph node medulla regulates the spatiotemporal unfolding of resident dendritic cell networks. | Immunity | 2023 | 37463581 | PubTator, text mining | PubMed |
| Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential. | Explor Target Antitumor Ther | 2023 | 37455828 | PubTator, text mining | PubMed |
| Mitochondrial quality control and its emerging role in the pathogenesis of diabetic kidney disease. | Kidney Res Clin Pract | 2023 | 37448292 | PubTator, text mining | PubMed |
| Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework. | Int J Mol Sci | 2023 | 37446102 | PubTator, text mining | PubMed |
| Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. | PLoS Negl Trop Dis | 2023 | 37440604 | PubTator, text mining | PubMed |
| Fluid protein fold space and its implications. | Bioessays | 2023 | 37431685 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer. | Cell Commun Signal | 2023 | 37430270 | PubTator, text mining | PubMed |
| The diverse effects of transforming growth factor-β and SMAD signaling pathways during the CTL response. | Front Immunol | 2023 | 37426662 | PubTator, text mining | PubMed |
| Restoring tumor immunogenicity with dendritic cell reprogramming. | Sci Immunol | 2023 | 37418548 | PubTator, text mining | PubMed |
| Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. | Nat Immunol | 2023 | 37414907 | PubTator, text mining | PubMed |
| Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer. | Aging (Albany NY) | 2023 | 37414093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/papers?page=11